AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BioHarvest Sciences Inc.

$1.8 -$3.41 (-65.45%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$1.85
Day Range
$1.8$1.85
Year Range
$1.8$12.8
Market Cap
31.19M
AVG Volume
46.63K
Trailing/Forward PE
-3.33/-
PEG ratio
0.09
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD)
010M20M30M40M2016201720182019202020212022202320242025
BHST Revenue (USD) by year
PeriodRevenue (USD)
202534.51M
202425.19M
202312.67M
20225.5M
20212.1M
2020396K
20190
20180
20170
20160
Net Income (USD)
-15M-10M-5M02016201720182019202020212022202320242025
BHST Net Income (USD) by year
PeriodNet Income (USD)
2025-11.13M
2024-12.91M
2023-12.56M
2022-11.24M
2021-9.83M
2020-6.58M
2019-2.75M
2018-4.23M
2017-131.75K
2016-102.87K
Operating Income (USD)
-15M-10M-5M02016201720182019202020212022202320242025
BHST Operating Income (USD) by year
PeriodOperating Income (USD)
2025-5.58M
2024-6.99M
2023-9.97M
2022-10.61M
2021-8.49M
2020-6.17M
2019-2.31M
2018-4.15M
2017-126.47K
2016-97.64K
EBITDA (USD)
-10M-7.5M-5M-2.5M02016201720182019202020212022202320242025
BHST EBITDA (USD) by year
PeriodEBITDA (USD)
2025-6.71M
2024-5.45M
2023-9.77M
2022-9.12M
2021-4.24M
2020-6.49M
2019-3.41M
2018-2.72M
2017-123.28K
2016-105.04K
Cash Flows (USD)
-15M-10M-5M02016201720182019202020212022202320242025
BHST Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-9.68M
2024-10.03M
2023-9.88M
2022-10.2M
2021-8.43M
2020-4.05M
2019-1.21M
2018-782.04K
2017-118.47K
2016-56.09K
EPS (USD)
-4-3-2-102016201720182019202020212022202320242025
BHST EPS (USD) by year
PeriodEPS (USD)
2025-0.63
2024-0.85
2023-0.94
2022-0.9
2021-0.81
2020-0.63
2019-0.74
2018-3.07
2017-0.27
2016-0.26
Expenses (USD)
-10M010M20M30MR&DSG&ACapex2016201720182019202020212022202320242025
BHST Expenses (USD) by year
PeriodExpenses (USD)
202526.83M
202423.32M
202316.9M
202212.88M
202110.53M
20205.75M
20191.01M
20181.96M
2017137.45K
2016131.94K
Cash & Debt (USD)
010M20M30MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
BHST Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202523.02M
20242.39M
20235.36M
20221.74M
20214.12M
20201.78M
201964K
2018627.27K
2017278.19K
201615.22K
Debt ratios
-0.75-0.5-0.2500.250.520182019202020212022202320242025
BHST Debt ratios by year
PeriodDebt ratios
20250.29
2024-0.4
2023-0.57
2022-0.38
20210.09
2020-0.07
20190.01
20180.2
Margins
0%20%40%60%202020212022202320242025
BHST Margins by year
PeriodMargins
202559.34%
202455.35%
202344.45%
202222.17%
202131.87%
202034.85%
Return on Capital
-1000%-500%0%500%2016201720182019202020212022202320242025
BHST Return on Capital by year
PeriodReturn on Capital
2025-43.76%
2024-970.9%
202384.59%
2022189.51%
2021-344.2%
2020286.88%
2019-84.9%
2018-111.61%
2017-37.29%
2016269.09%
Shares Outstanding
05M10M15M20M2016201720182019202020212022202320242025
BHST Shares Outstanding by year
PeriodShares Outstanding
202518.41M
202417.33M
202313.42M
202213.07M
202112.43M
202011.73M
20193.03M
20182.76M
2017726.49K
2016427.48K
Book Value Per Share (USD)
-2-10122016201720182019202020212022202320242025
BHST Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20251.38
20240.08
2023-1.11
2022-0.45
20210.23
2020-0.2
20191.07
20181.37
20170.49
2016-0.09
Total Assets (USD)
020M40M60M2016201720182019202020212022202320242025
BHST Total Assets (USD) by year
PeriodTotal Assets (USD)
202547.66M
202425M
202315M
20229.39M
202110.21M
20205.3M
20194.93M
20183.84M
2017369.95K
201681.92K
Free Cash Flow Yield
-30%-20%-10%0%med -9.92%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BHST Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-26.84%
Sep 26-26.11%
Sep 26-26.54%
Aug 26-26.26%
Aug 26-23.45%
Aug 26-23.34%
Aug 26-16.79%
Jul 26-19.9%
Jul 26-22.38%
Jul 26-15.92%
Jul 26-15.46%
Jul 26-14.97%
Jun 26-15.51%
Jun 26-13.18%
Jun 26-13.43%
Jun 26-13.47%
May 26-11.13%
May 26-11.13%
May 26-10.48%
May 26-13.25%
May 26-12.58%
Apr 26-12.01%
Apr 26-12.09%
Apr 26-12.2%
Apr 26-12.29%
Mar 26-11.39%
Mar 26-11.53%
Mar 26-11.86%
Mar 26-11.66%
Feb 26-10.45%
Feb 26-10.45%
Feb 26-10.32%
Feb 26-10.28%
Jan 26-10.02%
Jan 26-8.77%
Jan 26-10.09%
Jan 26-9.82%
Jan 26-9.45%
Dec 25-9.23%
Dec 25-9.41%
Dec 25-9.29%
Dec 25-7.81%
Nov 25-7.31%
Nov 25-8.24%
Nov 25-6.81%
Nov 25-7.55%
Oct 25-6.01%
Oct 25-4.68%
Oct 25-4.87%
Oct 25-4.88%
Oct 25-6.14%
Sep 25-4.94%
Sep 25-6.01%
Sep 25-6.11%
Sep 25-7.09%
Aug 25-6.58%
Aug 25-6.17%
Aug 25-5.78%
Aug 25-6.24%
Aug 25-7.11%
Jul 25-7.21%
Jul 25-7.9%
Jul 25-7.62%
Jul 25-7.93%
Jun 25-8.15%
Jun 25-7.75%
Jun 25-7.59%
Jun 25-7.86%
May 25-8.74%
May 25-8.69%
May 25-8.41%
May 25-10.21%
May 25-10.07%
Apr 25-10.04%
Apr 25-11.64%
Apr 25-11.72%
Apr 25-11.87%
Mar 25-8.38%
Mar 25-8.86%
Mar 25-9.4%
Mar 25-10.34%
Feb 25-10.5%
Feb 25-9.24%
Feb 25-9.52%
Feb 25-9.53%
Jan 25-11.09%
Jan 25-10.13%
Jan 25-9.43%
Jan 25-9.02%
Jan 25-8.76%
Dec 24-8.94%
Dec 24-8.74%
Dec 24-8.94%
Dec 24-9.09%
Nov 24-8.94%
Nov 24-10.34%
Nov 24-10.72%
Nov 24-11.46%
Nov 24-13.45%
Oct 24-13.4%
Price to Sales
02468med 4.13Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BHST Price to Sales by year
PeriodPrice to Sales
Sep 261.15
Sep 261.18
Sep 261.16
Aug 261.18
Aug 261.32
Aug 261.32
Aug 261.65
Jul 261.39
Jul 261.24
Jul 261.74
Jul 261.79
Jul 261.85
Jun 261.79
Jun 262.1
Jun 262.06
Jun 262.06
May 262.49
May 262.49
May 262.64
May 262.12
May 262.23
Apr 262.34
Apr 262.32
Apr 262.3
Apr 262.28
Mar 262.45
Mar 262.42
Mar 262.35
Mar 262.39
Feb 262.67
Feb 262.67
Feb 262.7
Feb 262.71
Jan 262.78
Jan 263.18
Jan 262.76
Jan 262.84
Jan 262.95
Dec 253.02
Dec 252.96
Dec 253
Dec 253.57
Nov 253.81
Nov 253.38
Nov 254.09
Nov 254.26
Oct 255.35
Oct 256.88
Oct 256.6
Oct 256.6
Oct 255.24
Sep 256.51
Sep 255.35
Sep 255.26
Sep 254.54
Aug 254.89
Aug 255.22
Aug 255.57
Aug 255.62
Aug 254.93
Jul 254.86
Jul 254.44
Jul 254.6
Jul 254.42
Jun 254.3
Jun 254.53
Jun 254.62
Jun 254.46
May 254.01
May 254.03
May 254.17
May 254.58
May 254.64
Apr 254.66
Apr 254.02
Apr 253.99
Apr 253.94
Mar 255.6
Mar 255.3
Mar 254.99
Mar 254.54
Feb 254.47
Feb 255.08
Feb 254.93
Feb 254.92
Jan 254.23
Jan 254.63
Jan 254.97
Jan 255.2
Jan 255.36
Dec 245.25
Dec 245.37
Dec 245.25
Dec 245.16
Nov 245.25
Nov 246.15
Nov 245.93
Nov 245.55
Nov 244.73
Oct 244.75
Price to Book
0255075100med 11.68Dec 24Feb 25Nov 25Jan 26Apr 26Jul 26Sep 26
BHST Price to Book by year
PeriodPrice to Book
Sep 262.06
Sep 262.12
Sep 262.09
Aug 262.11
Aug 262.36
Aug 262.37
Aug 262.52
Jul 262.13
Jul 261.89
Jul 262.66
Jul 262.74
Jul 262.83
Jun 262.73
Jun 263.21
Jun 263.15
Jun 263.14
May 263.8
May 263.8
May 264.04
May 262.87
May 263.02
Apr 263.17
Apr 263.15
Apr 263.12
Apr 263.1
Mar 269.73
Mar 269.62
Mar 269.35
Mar 269.51
Feb 2610.61
Feb 2610.61
Feb 2610.75
Feb 2610.79
Jan 2611.06
Jan 2612.64
Jan 2610.99
Jan 2611.29
Jan 2611.74
Dec 2512.01
Dec 2511.78
Dec 2511.94
Dec 2514.19
Nov 2515.16
Nov 2513.45
Nov 2516.29
May 2583.9
May 2585.08
Apr 2585.34
Apr 2573.61
Apr 2573.09
Apr 2572.18
Mar 2527.49
Mar 2526.02
Mar 2524.51
Mar 2522.29
Feb 2521.95
Feb 2524.93
Feb 2524.22
Feb 2524.18
Jan 2520.78
Jan 2522.75
Jan 2524.43
Jan 2525.56
Jan 2526.31
Dec 2425.77
Dec 2426.35
Dec 2425.77
Dec 2425.35
Nov 2425.77
Nov 2415.17
Nov 2414.64
Nov 2413.68
Nov 2411.66
Oct 2411.71
BioHarvest Sciences Inc.
BHST
Stockpicker

Video analysis: BHST

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BHST

BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product

newsfilecorp.com · 15 Sep 2026

BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product

Single-dose VINIA Daily Chews broaden demographics and usage occasions while demonstrating the commercial versatility of Botanical Synthesis Format expansion shows how BioHarvest can help CDMO partners move from plant-cell compositions to differentiated consumer products Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 15, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0), a Botanical Synthesis company developing and manufacturing proprietary plant-based compositions for customers and its own portfolio, today announced the launch of single-dose VINIA® Daily Chews. The new delivery format is designed to expand the addressable market for VINIA and to further demonstrate BioHarvest's progress toward leadership in industrial-scale Botanical Synthesis, the platform behind the Company's approach to consistent, full-spectrum plant compounds at scale.

BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference

newsfilecorp.com · 14 Sep 2026

BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 14, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will present at the H.C. Wainwright 28th Annual Global Investment Conference, to be held September 14-16, 2026, in New York City, NY.

Fiinu shares jump over 6% as Conister Bank platform enters production

proactiveinvestors.com · 4 Sep 2026

Fiinu shares jump over 6% as Conister Bank platform enters production

Fiinu (AIM: BANK), the UK fintech group, rose over 6% to 4p on Friday after its Plugin Overdraft platform moved into production ahead of a planned year-end...

BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing

proactiveinvestors.com · 3 Sep 2026

BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing

BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) plans to pursue a dual listing of its ordinary shares on the Tel Aviv Stock Exchange (TASE), with trading expected to begin on September 8, 2026. The company, which is listed on the Nasdaq Capital Market, expects the TASE listing to provide investors in Israel with access to its shares.

BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

newsfilecorp.com · 3 Sep 2026

BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development today announced its intention to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets. BioHarvest expects its shares to begin trading on the TASE on September 8, 2026.

BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript

seekingalpha.com · 11 Aug 2026

BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript

BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript

BioHarvest Sciences Q2 Earnings Call Highlights

marketbeat.com · 11 Aug 2026

BioHarvest Sciences Q2 Earnings Call Highlights

BioHarvest Sciences NASDAQ: BHST reported second-quarter 2026 revenue of $8.8 million, up 3.8% from $8.5 million a year earlier, while highlighting its first manufacturing and supply agreement within its contract development and manufacturing organization, or CDMO, business.

BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound

proactiveinvestors.com · 11 Aug 2026

BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound

BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) reported higher second-quarter revenue as the plant-based molecule developer shifted spending toward manufacturing capacity. Revenue for the quarter was $8.8 million, up 3.8% from a year earlier.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.